SYNTHESIS OF BIOLOGICALLY SIGNIFICANT INDOLES
具有生物学意义的吲哚的合成
基本信息
- 批准号:3755728
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
We propose to incorporate the indole moiety into 4-oxo-3-
quinolinecarboxylic acids, a new class of potent antimicrobial agents
also called "4-quinolones". Indoles having amine groups substituted in
all possible ring positions will be synthesized and utilized as
precursors of the potential antimicrobials. Condensation of these
aminoindoles with beta-dicarbonyl adducts will provide acrylates which
may be cyclized to the final 4-quinolone structure. Antimicrobial
susceptibility testing will take place under the auspices of sub-project
2 (Dr. Chopra).
We will also attempt to prepare Melatonin analogs with structural
modifications as suggested by National Cancer Institute (NCI) researchers
based upon the results of current testing for cell mitosis inhibition.
These new compounds will also be submitted to NCI for testing as cell
mitosis inhibitors. We also hope to evaluate the scope of the reaction
of indoles with sodium bisulfite due to its potential significance to
indole and medicinal chemistry.
To accomplish this work, we intend involving undergraduate students in
all aspects of the synthesis and characterization of these chemical
compounds which will utilize at least 12 different types of chemical
reactions some of which may be first-time applications in a specific
area. The project allows room for expansion and/or more detailed
examination of any particular facet of the research which may prove to
warrant such.
我们建议将吲哚部分引入4-氧代-3-
喹啉羧酸--一类新型高效抗菌剂
也称为“4-喹诺酮类”。含胺取代基的吲哚
所有可能的环位置都将被合成并用作
潜在抗菌剂的前体。这些凝结在一起
带有β-二羰基加合物的氨基吲哚将提供丙烯酸酯
可以环合成最终的4-喹诺酮结构。抗菌剂
药敏试验将在子项目的主持下进行
2(乔普拉博士)。
我们还将尝试用结构类似物制备褪黑激素类似物
国家癌症研究所(NCI)研究人员建议的修改
根据目前对细胞有丝分裂抑制的测试结果。
这些新化合物也将作为细胞提交给NCI进行测试
有丝分裂抑制药。我们还希望评估反应的范围。
含有亚硫酸氢钠的吲哚的潜在意义
吲哚和药物化学。
为了完成这项工作,我们打算让本科生参加
这些化合物的合成和表征的方方面面
将利用至少12种不同类型的化学品的化合物
反应,其中一些可能是第一次应用于特定的
区域。该项目允许扩展和/或更详细的空间
对研究的任何特定方面进行检查,这可能证明
有这样的理由。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
H F RUSSELL其他文献
H F RUSSELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('H F RUSSELL', 18)}}的其他基金
相似海外基金
Development of rapid detection method for drug-resistant bacteria in pulmonary MAC disease and search for new antibacterial agents
肺部MAC疾病耐药菌快速检测方法的建立及新型抗菌药物的寻找
- 批准号:
23K07930 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel antibacterial agents using crystal structure-based drug screening
利用基于晶体结构的药物筛选开发新型抗菌剂
- 批准号:
23K07918 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
ATP Synthase as an emerging target for the pre-clinical development of broad-spectrum antibacterial agents against drug-resistant bacterial infections
ATP 合酶作为针对耐药细菌感染的广谱抗菌药物临床前开发的新兴靶标
- 批准号:
472342 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Operating Grants
Clinical application of a rapid assay for antibacterial susceptibility test of beta-lactams and carbapenems antibacterial agents using MALDI-TOF MS
MALDI-TOF MS快速测定β-内酰胺类和碳青霉烯类抗菌药物药敏试验的临床应用
- 批准号:
22K07406 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tailored and uniform fibre-like micelles as antibacterial agents.
定制且均匀的纤维状胶束作为抗菌剂。
- 批准号:
569719-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Postgraduate Scholarships - Doctoral
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体
- 批准号:
531450-2018 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Collaborative Research and Development Grants
Novel silver nanoparticles as antibacterial agents
作为抗菌剂的新型银纳米颗粒
- 批准号:
521908-2018 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Collaborative Research and Development Grants
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体
- 批准号:
531450-2018 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Collaborative Research and Development Grants
Novel silver nanoparticles as antibacterial agents
作为抗菌剂的新型银纳米颗粒
- 批准号:
521908-2018 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Collaborative Research and Development Grants
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents.
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体。
- 批准号:
531450-2018 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Collaborative Research and Development Grants